Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?

Marco Caminati; Gabriella Guarnieri; Gianenrico Senna

doi:10.3390/vaccines9010038

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?

Vaccines (Basel). 2021 Jan 11;9(1):38. doi: 10.3390/vaccines9010038.

Authors

Marco Caminati¹, Gabriella Guarnieri², Gianenrico Senna^{1

3}

Affiliations

¹ Department of Medicine, University of Verona and Verona University Hospital, Piazzale L.A. Scuro, 10, 37134 Verona, Italy.
² Respiratory Pathophysiology Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padova, 35121 Padova, Italy.
³ Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, 37134 Verona, Italy.

Abstract

The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...].

Publication types

Editorial